Edition:
United States

Hubei Biocause Pharmaceutical Co Ltd (000627.SZ)

000627.SZ on Shenzhen Stock Exchange

6.84CNY
28 Apr 2017
Change (% chg)

¥-0.02 (-0.29%)
Prev Close
¥6.86
Open
¥6.86
Day's High
¥6.87
Day's Low
¥6.80
Volume
5,133,581
Avg. Vol
8,635,975
52-wk High
¥9.97
52-wk Low
¥6.73

Latest Key Developments (Source: Significant Developments)

Hubei Biocause Pharmaceutical to pay cash div 0.25 yuan per 10 shares for FY 2016
Tuesday, 25 Apr 2017 09:58pm EDT 

April 26 (Reuters) - Hubei Biocause Pharmaceutical Co Ltd <000627.SZ> ::* Says it plans to pay cash div 0.25 yuan per 10 shares for FY 2016.  Full Article

Hubei Biocause Pharma's net profit down in Q1, up in 2016
Tuesday, 25 Apr 2017 04:55am EDT 

April 25 (Reuters) - Hubei Biocause Pharmaceutical Co Ltd <000627.SZ>:Says 2016 net profit up 619.4 percent y/y at 1.8 billion yuan ($261.45 million).Says Q1 net profit down 86.1 percent y/y at 110.0 million yuan.  Full Article

Hubei Biocause Pharma sees Q1 net profit down after sharp rise in 2016
Wednesday, 12 Apr 2017 03:56am EDT 

Hubei Biocause Pharmaceutical Co Ltd <000627.SZ> : Says preliminary 2016 net profit up 626.0 percent y/y to 1.8 billion yuan ($261.13 million) . Says it sees Q1 net profit to fall 84.9-87.4 percent y/y to 100-120 million yuan .Says insurance unit's Q1 premium income at 22.3 billion yuan.  Full Article

Hubei Biocause Pharma's insurance unit posts premium income, to sell shares in Tianjin firm
Tuesday, 10 Jan 2017 03:58am EST 

Hubei Biocause Pharmaceutical Co Ltd <000627.SZ> : Says its life insurance unit's 2016 premium income at 26.6 billion yuan ($3.84 billion) .Says life insurance unit plans to sell up to 419.0 million shares in Tianjin Tianhai Investment <600751.SS>, representing 14.45 percent total issued share capital, in next 24 months.  Full Article

Hubei Biocause Pharmaceutical sees 2016 Q1 to Q3 net profit outlook to be 840 mln yuan to 860 mln yuan
Monday, 17 Oct 2016 04:11am EDT 

Hubei Biocause Pharmaceutical <000627.SZ>: Sees net profit for 2016 Q1 to Q3 to be 840 million yuan to 860 million yuan .Says the net profit of 2015 Q1 to Q3 was a loss of 55.8 million yuan.  Full Article

Hubei Biocause Pharmaceutical to return to net profit in Jan-Sept
Friday, 14 Oct 2016 04:50am EDT 

Hubei Biocause Pharmaceutical Co Ltd <000627.SZ> : Says it expects to return to net profit of 840-860 million yuan ($125.967-$128.96 million) in jan-sept versus net loss of 55.8 million yuan year ago .Says life insurance unit's 9-month premium income at 22.15 billion yuan.  Full Article

Hubei Biocause Pharma returns to net profit of 830.2 mln yuan in H1
Monday, 29 Aug 2016 04:11am EDT 

Hubei Biocause Pharmaceutical Co Ltd <000627.SZ> :Says it returns to net profit of 830.2 million yuan ($124.31 million) in H1 versus net loss of 37.2 million yuna year ago.  Full Article

Hubei Biocause Pharmaceutical expects to post 820-840 mln yuan profit in 2016 H1
Thursday, 14 Jul 2016 03:53am EDT 

Hubei Biocause Pharmaceutical Co., Ltd. <000627.SZ>: Says it expects 2016 H1 net profit of 820-840 million yuan, to be out of the red compared with 2015 H1 . Says 2015 H1 net loss of 38 million yuan .Says increased revenue from acquired equity is the main reason for the forecast.  Full Article

Hubei Biocause Pharma to return to net profit in H1
Wednesday, 13 Jul 2016 04:42am EDT 

Hubei Biocause Pharmaceutical Co Ltd <000627.SZ> :Says it expects H1 to return to net profit at 820-840 million yuan ($122.56-$125.55 million) versus net loss of 38 million yuan year ago.  Full Article

Hubei Biocause Pharma's insurance unit posts premium income for Jan-May
Monday, 13 Jun 2016 11:52pm EDT 

Hubei Biocause Pharmaceutical Co Ltd <000627.SZ> :Says insurance unit's January-May premium income totalling 19.7 billion yuan ($2.99 billion).  Full Article

More From Around the Web